ABVC·00091F304·US·equity·Healthcare - Biotechnology-Activist
ABVC (ABVC BIOPHARMA INC) is held by 9 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($214,598), RENAISSANCE TECHNOLOGIES LLC ($92,257), STATE STREET CORP ($70,623). Net institutional sentiment: Mixed.
See how ABVC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer